Knockdown of PSMD3 resulted in reduced survival of FLT3+ AML cells in colony formation assays (Figure 2C,D,right), which correlated with better OS when injected into immunocompromised recipient mice (Figure 3). This evidence concerns the gene FLT3 and acute myeloid leukemia.